A Phase III, Long-Term, Randomized, Double-blind, Placebo-controlled Trial of BHV-4157 in Adult Subjects With Spinocerebellar Ataxia
Not yet recruiting
Phase of Trial: Phase III
Latest Information Update: 19 Feb 2019
At a glance
- Drugs Trigriluzole (Primary)
- Indications Spinocerebellar ataxias
- Focus Registrational; Therapeutic Use
- Sponsors Biohaven Pharmaceutical; Biohaven Pharmaceutical Holding Company
- 11 Feb 2019 Planned initiation date changed from 31 Jan 2019 to 15 Mar 2019.
- 17 Dec 2018 Planned initiation date changed from 15 Nov 2018 to 31 Jan 2019.
- 08 Oct 2018 Status changed from planning to not yet recruiting.